- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 4 residues within 4Å:- Chain A: E.95, N.659, K.785
- Ligands: ATP.1
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.95, H2O.4, H2O.4
MG.12: 4 residues within 4Å:- Chain C: E.95, N.659, K.785
- Ligands: ATP.11
3 PLIP interactions:1 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.95, H2O.11, H2O.12
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 7 residues within 4Å:- Chain A: G.245, E.247, G.248, G.512, V.513, F.514, I.515
Ligand excluded by PLIPCL.4: 7 residues within 4Å:- Chain A: S.204, I.206, G.248, G.512, V.513, F.514, Y.602
Ligand excluded by PLIPCL.5: 6 residues within 4Å:- Chain A: A.202, G.203, S.204, G.205, P.207, Q.208
Ligand excluded by PLIPCL.13: 7 residues within 4Å:- Chain C: G.245, E.247, G.248, G.512, V.513, F.514, I.515
Ligand excluded by PLIPCL.14: 7 residues within 4Å:- Chain C: S.204, I.206, G.248, G.512, V.513, F.514, Y.602
Ligand excluded by PLIPCL.15: 6 residues within 4Å:- Chain C: A.202, G.203, S.204, G.205, P.207, Q.208
Ligand excluded by PLIP- 2 x 01: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1S,2R,3S,4R,5R,6R)-2,4,5-tris(oxidanyl)-3,6-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate
01.6: 23 residues within 4Å:- Chain A: L.132, L.136, V.140, V.222, R.223, L.224, L.227, V.256, A.259, G.260, I.261, Q.263, G.264, R.265, S.266, T.267, S.268, F.273, I.275, F.276, K.285, P.716, R.717
29 PLIP interactions:29 interactions with chain A- Hydrophobic interactions: A:L.132, A:L.136, A:L.136, A:V.140, A:L.227, A:F.273, A:F.273, A:I.275, A:F.276
- Hydrogen bonds: A:R.223, A:L.224, A:S.266, A:T.267, A:T.267, A:T.267, A:S.268, A:K.285, A:K.285, A:R.717
- Water bridges: A:H.220, A:H.220, A:R.223, A:K.225, A:R.265, A:R.265, A:R.717
- Salt bridges: A:R.223, A:R.265, A:R.717
01.16: 23 residues within 4Å:- Chain C: L.132, L.136, V.222, R.223, L.224, L.227, V.256, I.257, A.259, G.260, I.261, Q.263, G.264, R.265, S.266, T.267, S.268, F.273, I.275, F.276, K.285, P.716, R.717
25 PLIP interactions:25 interactions with chain C- Hydrophobic interactions: C:L.132, C:L.136, C:L.227, C:F.273, C:F.276
- Hydrogen bonds: C:R.223, C:L.224, C:I.261, C:S.266, C:T.267, C:T.267, C:S.268, C:K.285, C:K.285, C:R.717
- Water bridges: C:H.220, C:H.220, C:R.223, C:K.225, C:R.265, C:R.265, C:R.717
- Salt bridges: C:R.223, C:R.265, C:R.717
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.7: 8 residues within 4Å:- Chain A: V.387, A.390, V.391, A.394, Y.397, F.597, I.598, E.599
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:V.387, A:V.387, A:A.390, A:V.391, A:A.394, A:Y.397, A:F.597, A:F.597, A:F.597, A:F.597, A:I.598
Y01.8: 10 residues within 4Å:- Chain A: V.430, Y.433, S.434, F.453
- Chain B: T.282, I.286, S.289, V.290, L.293, F.294
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:I.286, B:I.286, B:V.290, B:L.293, B:F.294, A:V.430, A:Y.433
- Hydrogen bonds: B:T.282
Y01.9: 8 residues within 4Å:- Chain A: V.189, I.193, I.197, K.225, V.228, I.229, S.232, L.236
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.189, A:I.193, A:I.197, A:V.228, A:L.236
- Salt bridges: A:K.225
Y01.10: 8 residues within 4Å:- Chain A: W.398, F.402, V.423, F.499, L.500, W.503
- Chain B: Y.300, F.304
8 PLIP interactions:2 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:Y.300, B:Y.300, A:V.423, A:F.499, A:L.500, A:W.503, A:W.503, A:W.503
Y01.17: 7 residues within 4Å:- Chain C: V.387, A.390, V.391, A.394, Y.397, F.597, E.599
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:V.387, C:V.387, C:A.390, C:V.391, C:A.394, C:Y.397, C:F.597, C:F.597, C:F.597
Y01.18: 8 residues within 4Å:- Chain C: V.430, Y.433, S.434, F.453
- Chain D: I.286, S.289, L.293, F.294
4 PLIP interactions:1 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:V.430, D:I.286, D:I.286, D:L.293
Y01.19: 8 residues within 4Å:- Chain C: F.143, V.147, L.151, I.193, I.197, K.225, S.232, I.235
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:F.143, C:V.147, C:L.151, C:I.193, C:I.197, C:I.235
- Salt bridges: C:K.225
Y01.20: 6 residues within 4Å:- Chain C: V.423, F.499, W.503
- Chain D: Y.300, L.301, F.304
8 PLIP interactions:5 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:V.423, C:F.499, C:W.503, C:W.503, C:W.503, D:Y.300, D:Y.300, D:L.301
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hilton, J. et al., Mechanism of phosphoinositide regulation of lysosomal pH via inhibition of CLC7. To Be Published
- Release Date
- 2025-07-30
- Peptides
- H(+)/Cl(-) exchange transporter 7: AC
Osteopetrosis-associated transmembrane protein 1: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x 01: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1S,2R,3S,4R,5R,6R)-2,4,5-tris(oxidanyl)-3,6-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hilton, J. et al., Mechanism of phosphoinositide regulation of lysosomal pH via inhibition of CLC7. To Be Published
- Release Date
- 2025-07-30
- Peptides
- H(+)/Cl(-) exchange transporter 7: AC
Osteopetrosis-associated transmembrane protein 1: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D - Membrane
-
We predict this structure to be a membrane protein.